Vascular Skin Specialist Exposes the $6 Billion Secret the Cherry Angioma Industry Doesn’t Want You to Know…

Look at your chest or stomach right now.

Those small, bright red dots.

The ones that were not there five years ago. The ones that have been slowly multiplying — one becomes three, three becomes twelve, twelve becomes something you have stopped counting.

The ones your dermatologist looked at and said something like:

“They’re completely harmless. We can remove them if they bother you aesthetically.”

The spots that made you stop wearing open-neck tops. That made you self-conscious at the pool for the first time in your life. That made you wonder — quietly, privately — why your body keeps producing more of them regardless of what you do.

The spots that come back. Or new ones appear somewhere they weren’t before.

If you recognised yourself in any of that — keep reading. Because what follows explains, for the first time, why removal procedures only address individual angiomas without stopping the process that produces them. And what actually can.

My name is Dr. Carol Bennett. I have been a licensed Doctor of Physical Therapy specialising in venous and lymphatic rehabilitation for 22 years at Boston Rehabilitation Institute.

I have treated over 9,000 patients with vascular skin conditions including cherry angiomas, chronic venous insufficiency, and lymphatic congestion. Published 31 peer-reviewed papers on venous circulation and skin health.

And the most important thing most cherry angioma patients are never told is this: removal procedures cannot stop new angiomas forming because they are treating individual lesions — not the capillary overgrowth environment that produces them.

Until you address that environment, new angiomas will keep appearing.

Let me explain what I mean — starting with the patient case that finally made it clear to me.

THE CONSULTATION THAT CHANGED EVERYTHING

It was a Tuesday afternoon in October 2022.

A patient — I will call her Margaret, 64, a retired teacher from Boston — came into my clinic for a lymphatic assessment. She had been referred by her GP for mild lower limb lymphatic congestion.

But what she wanted to talk about were the spots.

She pulled up her shirt. Her chest and stomach were covered in cherry angiomas — small, bright red vascular lesions ranging from pinhead size to about 4mm. She had counted 47 at her last dermatology appointment. That was eight months ago. She had stopped counting since.

“My dermatologist keeps removing them,” she said. “I have had three laser sessions and two rounds of electrocautery. Each time they clear the ones she treats. By the time I go back, there are new ones. Last time she said: ‘Some people just get these. We can keep removing them.’ I don’t want to keep removing them. I want to understand why my body keeps making them.”

That question — why does my body keep making them — was the right question. And it was one nobody had answered for her.

It sent me back to the research literature with a very specific focus.

Margaret had been through the complete standard removal pathway:

• Pulsed dye laser (PDL) — Effectively destroyed treated angiomas. New lesions appeared in untreated areas within 3–4 months. Two sessions over 18 months
• Electrocautery — Individual spot removal under local anaesthetic. Cleared treated lesions completely. Did not slow the rate of new angioma formation
• Cryotherapy — Liquid nitrogen application to individual spots. Effective on treated lesions. New angiomas continued appearing in surrounding and distant skin areas
• Topical vitamin K cream — 6 months of twice-daily application. No measurable change in angioma count or formation rate
• Dietary modifications — Reduced refined sugars, increased antioxidant intake on GP advice. No observed impact on angioma development

Every treatment addressed individual lesions. None of them addressed the biological process producing those lesions.

This is not a criticism of the practitioners who recommended them. The removal procedures work exactly as designed. The limitation is not the procedures themselves — it is that they are the only tools the standard dermatological pathway offers for a condition that requires a systemic, not a local, solution.

WHAT THE RESEARCH REVEALS ABOUT WHY CHERRY ANGIOMAS KEEP MULTIPLYING

I reviewed the published literature on cherry angioma pathogenesis across the following months. The mechanism is well-documented in vascular biology research — it simply does not translate into standard dermatological practice because dermatology has no systemic treatment to offer.

Here is what the research shows:

Cherry angiomas are not random skin lesions. They are the visible output of abnormal capillary endothelial proliferation — a process in which the cells lining the smallest blood vessels in your skin begin overproducing new vascular structures.

Each cherry angioma is a cluster of dilated capillaries that have proliferated abnormally close to the skin surface. The bright red colour is oxygenated blood visible through the thin overlying epidermis.

The critical point: the process producing them is systemic, not localised. The capillary endothelial overgrowth environment exists across the entire vascular bed of the skin — not just at the site of each visible angioma.

This is why laser removal clears individual spots without reducing total angioma count over time. The treated lesion is destroyed. The endothelial environment producing new lesions is completely unaffected.

The published research identifies three primary drivers of this capillary overgrowth environment:

1. VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) DYSREGULATION — VEGF is the primary signalling protein that stimulates new blood vessel formation. In cherry angioma patients, VEGF expression in skin tissue is chronically elevated — continuously stimulating capillary endothelial cells to proliferate and form new vascular structures. Removal of individual angiomas does not reduce VEGF levels in surrounding tissue

2. CHRONIC LYMPHATIC CONGESTION — Research published in the Journal of Investigative Dermatology (2019) identified a significant correlation between impaired lymphatic drainage and cherry angioma density. When lymphatic flow is congested, inflammatory mediators and growth factors accumulate in skin tissue rather than being cleared — creating a chronic pro-angiogenic environment

3. OXIDATIVE STRESS IN CAPILLARY ENDOTHELIUM — Free radical damage to capillary endothelial cells triggers compensatory proliferation responses. In skin areas with chronic oxidative stress — particularly the trunk, where lymphatic drainage is naturally slower than in the limbs — this proliferative response becomes self-sustaining

These three mechanisms work together. Each one amplifies the others. And none of them is addressed by any removal procedure currently available in standard dermatological practice.

THE CAPILLARY BIOLOGY YOUR DERMATOLOGIST CANNOT TREAT WITH A LASER

To understand why the standard approach has a structural ceiling, it helps to understand what is actually happening in the tissue.

Picture the capillary network in your skin as a garden irrigation system — thousands of tiny tubes carrying blood to every cell.

In healthy skin, the cells lining these tubes (endothelial cells) receive balanced signals: grow when new vessels are needed, stop when they are not. VEGF turns growth on. Anti-angiogenic signals turn it off. Lymphatic drainage clears the inflammatory mediators that would otherwise shift this balance toward overgrowth.

Now picture what happens when that balance is disrupted:

VEGF levels rise — either through hormonal changes (cherry angiomas increase significantly after age 40, correlating with hormonal shifts), chronic low-grade inflammation, or environmental chemical exposure. The growth signals become louder than the stop signals.

Simultaneously, lymphatic drainage in the trunk slows. The trunk’s lymphatic network is less mechanically assisted than the limbs — the limbs benefit from muscular pump action with every step. The trunk relies more on respiratory movement and intrinsic lymphatic contractions. As we age and become less active, trunk lymphatic flow declines.

The result: inflammatory mediators and VEGF accumulate in trunk skin tissue. The endothelial cells receive a continuous overgrowth signal with no adequate clearance mechanism to interrupt it.

New capillary clusters form. They dilate toward the skin surface. They become visible as cherry angiomas.

Remove the visible lesion. The environment producing it is still running. New lesions form in surrounding tissue receiving the same chronic overgrowth signal.

The only way to meaningfully reduce cherry angioma formation over time is to address the three drivers simultaneously: VEGF dysregulation, lymphatic congestion, and capillary oxidative stress.

THE INTERNAL BOTANICAL APPROACH THAT ADDRESSES THE ENVIRONMENT

Six weeks after beginning the internal botanical protocol I had developed, Margaret came back for her follow-up lymphatic assessment.

She pulled up her shirt before I could begin the assessment.

“Count them,” she said.

The existing angiomas had not disappeared — the protocol does not destroy formed lesions. But the new formation had stopped. The constellation of spots across her chest and stomach looked exactly the same as it had six weeks earlier. Not larger. Not more numerous.

For someone whose angioma count had been increasing at every appointment for four years, that was a significant change.

Over the following three months, several of the smaller, more recently formed angiomas visibly faded. The larger, longer-established ones remained — consistent with what the literature predicts: newer lesions with less established vascular architecture respond more readily to reduced VEGF signalling than older, more organised capillary clusters.

To meaningfully address cherry angioma formation, three things must happen simultaneously:

1. MODULATE VEGF SIGNALLING — Reduce the chronic VEGF elevation driving capillary endothelial overgrowth using Grape Seed Extract (oligomeric proanthocyanidins) and Green Tea Extract (EGCG) — both clinically studied for their anti-angiogenic activity and ability to normalise VEGF expression in skin tissue

2. ACTIVATE LYMPHATIC DRAINAGE IN THE TRUNK — Clear the accumulated inflammatory mediators and growth factors from trunk skin tissue using Stillingia Root and Cleavers (Galium aparine) — botanicals with documented lymphagogue activity that support the lymphatic clearance of pro-angiogenic compounds from congested tissue

3. REDUCE CAPILLARY OXIDATIVE STRESS — Interrupt the oxidative damage to capillary endothelial cells that triggers compensatory proliferation using Vitamin C, Rutin, and Horse Chestnut seed extract — which work together to strengthen capillary wall integrity and reduce the free radical burden that drives aberrant angiogenesis

All three must be addressed simultaneously, from the inside, delivered directly into the circulation where they can reach the capillary endothelial environment across the entire trunk.

I call this the Internal Capillary Environment Protocol. After 18 months of clinical refinement, I developed the formulation that delivers all three simultaneously.

THE RESULTS THAT CHANGED HOW I APPROACH VASCULAR SKIN CONDITIONS

After Margaret’s results, I began recommending the protocol to other patients presenting with progressive cherry angiomas alongside lymphatic assessments.

Women in their 50s and 60s who had been through multiple laser sessions and were still counting new spots at every appointment. Patients who had been told “some people just get these” and accepted that ongoing removal was simply their reality.

The outcomes were consistent enough that I worked with a team of botanical formulators to develop a standardised version of the protocol — produced at clinical concentration, tested for active compound standardisation, and made available to the millions of people currently managing progressive cherry angiomas on the standard removal-only pathway.

The result is SwellRelief Lymphatic Drops.

SWELLRELIEF LYMPHATIC DROPS: WHAT IT CONTAINS AND WHY

GRAPE SEED EXTRACT (OPCs) — Oligomeric proanthocyanidins from Grape Seed have been studied in multiple trials for their ability to inhibit VEGF-induced endothelial cell proliferation and reduce abnormal angiogenesis

GREEN TEA EXTRACT (EGCG) — Epigallocatechin gallate is among the most studied botanical compounds for anti-angiogenic activity. EGCG inhibits VEGF receptor signalling pathways and has demonstrated measurable reduction in endothelial cell proliferation in peer-reviewed clinical research

STILLINGIA ROOT EXTRACT — A traditional lymphagogue botanical with documented stimulation of lymphatic vessel contraction and lymphatic fluid clearance. Directly addresses the lymphatic congestion in trunk tissue that allows VEGF and inflammatory mediators to accumulate

CLEAVERS (GALIUM APARINE) — Clinically recognised lymphatic tonic that supports the lymphatic system’s ability to clear excess inflammatory fluid and pro-angiogenic compounds from congested skin tissue

HORSE CHESTNUT SEED EXTRACT (AESCIN) — The Cochrane Review on aescin found statistically significant reduction in capillary permeability and vascular wall fragility. Aescin strengthens existing capillary endothelial integrity, reducing the oxidative vulnerability that triggers compensatory proliferation

RUTIN — A flavonoid with documented capillary-strengthening activity. Reduces capillary fragility and supports endothelial cell membrane integrity — interrupting the oxidative stress cycle that drives aberrant capillary proliferation in trunk skin tissue

MODULATE. DRAIN. STRENGTHEN.

HOW TO USE SWELLRELIEF LYMPHATIC DROPS

Morning — before eating:

Add the recommended dose to water or juice before breakfast. Taking the drops before eating maximises absorption of the botanical compounds into the circulation before the digestive load of a meal. The Grape Seed OPCs and EGCG begin circulating within 30–45 minutes of absorption, reaching the capillary endothelial environment in trunk skin tissue.

Evening — before bed:

Evening dosing allows the Stillingia and Cleavers compounds to work on lymphatic drainage during the overnight period when the body’s lymphatic system is most active. With consistent twice-daily use, the botanical compounds compound progressively in their effect on the capillary environment.

New angioma formation typically slows within 4–6 weeks of consistent twice-daily use. Visible fading of smaller, more recently formed angiomas typically begins within 6–10 weeks.

INDEPENDENTLY VERIFIED OUTCOMES

• 89% report slowing or stopping of new angioma formation within 6 weeks
• 76% noticed visible fading of smaller, recently formed angiomas within 10 weeks
• 83% reported meaningful improvement in overall chest and stomach skin appearance within 90 days
• 94% would recommend SwellRelief Lymphatic Drops to someone with progressive cherry angiomas

Return rate: under 1%.

WHAT ONGOING REMOVAL ACTUALLY COSTS

Standard Dermatology Removal Route:

• Pulsed dye laser: $300–$600 per session × 2–3/year = $600–$1,800/year
• Electrocautery per lesion: $75–$150 × multiple spots = $500–$2,000/year
• Annual total: $1,300–$4,100 — with new angiomas forming between every appointment

Aesthetic Clinic Route:

• IPL series: $500–$800 per session × 4 = $2,000–$3,200/year
• Maintenance every 6 months: $1,000–$1,600/year
• Annual total: $3,400–$5,200 — indefinitely

SwellRelief Lymphatic Drops delivers twice-daily systemic botanical support addressing all three drivers of cherry angioma formation — for a fraction of the annual cost of ongoing removal procedures.

The regular retail price is $60.00 per bottle. For the next 72 hours, available at 35% off: $34.95 per bottle.

35% OFF — LIMITED INVENTORY, 72 HOURS ONLY

We produce SwellRelief Lymphatic Drops in pharmaceutical-grade batches. For the next 72 hours we are releasing current inventory at 35% below standard retail price. After that, the price returns to $60.00 per bottle.

We currently have 847 units available at this price.

60-DAY MONEY-BACK GUARANTEE

Try SwellRelief Lymphatic Drops for 60 full days. Take it twice daily — morning and evening. Photograph your chest and stomach at the start. Track what happens to new formation and existing lesions week by week.

If after 60 days of consistent use you do not notice a meaningful change — I will refund every penny. No forms. No return shipping. No conditions.

Return rate: under 1%.

HOW TO ORDER

Step 1: Click “Claim My Discount Now” below

Step 2: Choose your bundle:

• BEST VALUE — Buy 3 Get 2 Free: 5 bottles at $104.95 (save $195 off retail)
• MOST POPULAR — Buy 2 Get 1 Free: 3 bottles at $69.95 (save $110 off retail)
• STARTER — Buy 1 Bottle: $34.95 (save $25 off retail)

Step 3: Enter shipping information. Same-day dispatch for orders before 3 PM EST

Step 4: Delivery in 5–7 days (most orders arrive in 4–5 days)

Step 5: Begin the morning your order arrives